Shanghai Clinical Research Center (SCRC) functions as a 3rd-party full-service assessment and resource center dedicated to streamlining drug development. Established in 2008, it is spearheading the advancement of drug development services in China through a comprehensive platform encompassing clinical research sites nationwide. SCRC boasts a fully equipped central laboratory with GLP capabilities, cutting-edge data management, and bio-statistics systems, positioning it as a frontrunner in the industry.
Founded in collaboration with the Ministry of Science and Technology and the Shanghai Municipality, SCRC aims to play a pivotal role in the global expansion of drug development in China. By bridging the gap between pharmaceutical companies and hospitals, the company is poised to facilitate crucial connections within the industry.
There is no investment information
No recent news or press coverage available for Shanghai Clinical Research Center.